Skip to main content
Top
Published in: Cancer Causes & Control 1/2007

01-02-2007 | Review

Trace elements and cancer risk: a review of the epidemiologic evidence

Authors: Stephanie A. Navarro Silvera, Thomas E. Rohan

Published in: Cancer Causes & Control | Issue 1/2007

Login to get access

Abstract

Worldwide, there are more than 10 million new cancer cases each year, and cancer is the cause of approximately 12% of all deaths. Given this, a large number of epidemiologic studies have been undertaken to identify potential risk factors for cancer, amongst which the association with trace elements has received considerable attention. Trace elements, such as selenium, zinc, arsenic, cadmium, and nickel, are found naturally in the environment, and human exposure derives from a variety of sources, including air, drinking water, and food. Trace elements are of particular interest given that the levels of exposure to them are potentially modifiable. In this review, we focus largely on the association between each of the trace elements noted above and risk of cancers of the lung, breast, colorectum, prostate, urinary bladder, and stomach. Overall, the evidence currently available appears to support an inverse association between selenium exposure and prostate cancer risk, and possibly also a reduction in risk with respect to lung cancer, although additional prospective studies are needed. There is also limited evidence for an inverse association between zinc and breast cancer, and again, prospective studies are needed to confirm this. Most studies have reported no association between selenium and risk of breast, colorectal, and stomach cancer, and between zinc and prostate cancer risk. There is compelling evidence in support of positive associations between arsenic and risk of both lung and bladder cancers, and between cadmium and lung cancer risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108PubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108PubMed
2.
go back to reference World Health Organization (1996) Trace elements in human nutrition and health. World Health Organization, Geneva World Health Organization (1996) Trace elements in human nutrition and health. World Health Organization, Geneva
3.
5.
go back to reference Sattar N, Scott HR, McMillan DC, Talwar D, O’Reilly DSJ, Fell GS (1997) Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer 28:308–312PubMedCrossRef Sattar N, Scott HR, McMillan DC, Talwar D, O’Reilly DSJ, Fell GS (1997) Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer 28:308–312PubMedCrossRef
6.
go back to reference Blot WJ, Brown LM, Pottern LM, Stone BJ, Fraumeni Jr JF (1983) Lung cancer among long-term steel workers. Am J Epidemiol 117:706–716PubMed Blot WJ, Brown LM, Pottern LM, Stone BJ, Fraumeni Jr JF (1983) Lung cancer among long-term steel workers. Am J Epidemiol 117:706–716PubMed
7.
8.
go back to reference International Agency for Research on Cancer (IARC) (1993) IARC monographs on the evaluation of the carcinogenic risk to man: beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions. IARC Press, Lyon International Agency for Research on Cancer (IARC) (1993) IARC monographs on the evaluation of the carcinogenic risk to man: beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions. IARC Press, Lyon
9.
go back to reference International Agency for Research on Cancer (IARC) (1999) Arsenic and arsenic compounds. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. IARC, Lyon (France). Report No.: Supplement 7 International Agency for Research on Cancer (IARC) (1999) Arsenic and arsenic compounds. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. IARC, Lyon (France). Report No.: Supplement 7
10.
go back to reference International Agency for Research on Cancer (IARC) (1990) Chromium, nickel and welding. IARC Monogr Eval Carcinog Risk Chem Man 49:1–648 International Agency for Research on Cancer (IARC) (1990) Chromium, nickel and welding. IARC Monogr Eval Carcinog Risk Chem Man 49:1–648
11.
go back to reference Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for arsenic. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-38-2 Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for arsenic. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-38-2
12.
go back to reference Rasmussen L, Andersen KJ (2003) Environmental health and human exposure assessment. In: World Health Organization, UNICEF, editors. Arsenic in drinking water. IWA, London, pp 67–168 Rasmussen L, Andersen KJ (2003) Environmental health and human exposure assessment. In: World Health Organization, UNICEF, editors. Arsenic in drinking water. IWA, London, pp 67–168
13.
go back to reference Agency for Toxic Substances and Disease Registry (ATSDR) (1999) Toxicological profile for cadmium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-43-9 Agency for Toxic Substances and Disease Registry (ATSDR) (1999) Toxicological profile for cadmium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-43-9
14.
go back to reference WHO Regional Office for Europe (2000) Air quality guidelines, 2nd edn. World Health Organization, Copenhagen, Denmark WHO Regional Office for Europe (2000) Air quality guidelines, 2nd edn. World Health Organization, Copenhagen, Denmark
15.
go back to reference Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for nickel. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-02-0 Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for nickel. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-02-0
16.
go back to reference Lamm SH, Engel A, Kruse MB, et al (2004) Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 46:298–306PubMedCrossRef Lamm SH, Engel A, Kruse MB, et al (2004) Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 46:298–306PubMedCrossRef
17.
go back to reference Agency for Toxic Substances, Disease Registry (ATSDR) (2003) Toxicological profile for zinc. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-66-6 Agency for Toxic Substances, Disease Registry (ATSDR) (2003) Toxicological profile for zinc. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-66-6
18.
go back to reference Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for selenium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7782-49-2 Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for selenium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7782-49-2
19.
go back to reference Abdulla M, Parr RM, Iyengar GV (1993) Trace element requirements, intake and recommendations. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 311–328 Abdulla M, Parr RM, Iyengar GV (1993) Trace element requirements, intake and recommendations. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 311–328
20.
go back to reference Hunter, D, Morris, JS, Chute, CG, et al. 1990Predictors of selenium concentration in human toenailsAm J Epidemiol132114122PubMed Hunter, D, Morris, JS, Chute, CG,  et al. 1990Predictors of selenium concentration in human toenailsAm J Epidemiol132114122PubMed
21.
go back to reference Burguera JL, Burguera M, Gallignani M, Alarcon OM, Burguera JA (1990) Blood serum selenium in the province of Merida, Venezuela, related to sex, cancer incidence, and soil selenium contnet. J Trace Elem Electrolytes Health Dis 4:73–77PubMed Burguera JL, Burguera M, Gallignani M, Alarcon OM, Burguera JA (1990) Blood serum selenium in the province of Merida, Venezuela, related to sex, cancer incidence, and soil selenium contnet. J Trace Elem Electrolytes Health Dis 4:73–77PubMed
22.
go back to reference Agency for Toxic Substances and Disease Registry (ATSDR) (2001) ToxFAQs. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA Agency for Toxic Substances and Disease Registry (ATSDR) (2001) ToxFAQs. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA
23.
go back to reference Meyer F, Verreault R (1987) Erythrocyte selemium and breast cancer risk. Am J Epidemiol 125:917–919PubMed Meyer F, Verreault R (1987) Erythrocyte selemium and breast cancer risk. Am J Epidemiol 125:917–919PubMed
24.
go back to reference Garland M, Morris JS, Rosner B, et al (1993) Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493–497 Garland M, Morris JS, Rosner B, et al (1993) Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493–497
25.
go back to reference Swanson CA, Longnecker MP, Veillon C, et al (1990) Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in seleniferous area. Am J Clin Nutr 52:858–862PubMed Swanson CA, Longnecker MP, Veillon C, et al (1990) Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in seleniferous area. Am J Clin Nutr 52:858–862PubMed
26.
go back to reference Longnecker MP, Stram DO, Taylor PA, et al (1996) Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiol 7:384–390 Longnecker MP, Stram DO, Taylor PA, et al (1996) Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiol 7:384–390
27.
go back to reference Agahian B, Lee JS, Nelson JH, John RE (1990) Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind Hyg Assoc J 51:646–651PubMed Agahian B, Lee JS, Nelson JH, John RE (1990) Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind Hyg Assoc J 51:646–651PubMed
28.
29.
go back to reference Wood RJ (2000) Assessment of marginal zinc status in humans. J Nutr 130:1350S–1354SPubMed Wood RJ (2000) Assessment of marginal zinc status in humans. J Nutr 130:1350S–1354SPubMed
30.
go back to reference Nielsen FH (1993) Ultratrace elements of possible importance for human health: an update. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 355–376 Nielsen FH (1993) Ultratrace elements of possible importance for human health: an update. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 355–376
31.
go back to reference Uthus EO, Seaborn CD (1996) Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations of the other trace elements. J Nutr 126:2452S–2459SPubMed Uthus EO, Seaborn CD (1996) Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations of the other trace elements. J Nutr 126:2452S–2459SPubMed
32.
go back to reference Leonard A, Gerber GB (1994) Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat Res 317:81–88PubMed Leonard A, Gerber GB (1994) Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat Res 317:81–88PubMed
33.
go back to reference Hossain K, Akhand AA, Kato M, et al (2000) Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol 165:4290–4297PubMed Hossain K, Akhand AA, Kato M, et al (2000) Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol 165:4290–4297PubMed
34.
go back to reference Chen W, Martindale JL, Holbrook NJ, Liu Y (1998) Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol Cell Biol 18:5178–5188PubMed Chen W, Martindale JL, Holbrook NJ, Liu Y (1998) Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol Cell Biol 18:5178–5188PubMed
35.
go back to reference Office of Environmental Health Hazard Assessment (2004) Public health goal for arsenic in drinking water. California Environmental Protection Agency Office of Environmental Health Hazard Assessment (2004) Public health goal for arsenic in drinking water. California Environmental Protection Agency
36.
go back to reference Bates MN, Smith AH, Hopenhayn-Rich C (1992) Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462–476PubMed Bates MN, Smith AH, Hopenhayn-Rich C (1992) Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462–476PubMed
37.
go back to reference Chen CJ, Chuang YC, You SL, Lin HY (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399–405PubMed Chen CJ, Chuang YC, You SL, Lin HY (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399–405PubMed
38.
go back to reference Ferreccio C, Gonzalez PC, Milosavjlevic SV, Marshall GG, Sancha AM, Smith AH (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673–679PubMedCrossRef Ferreccio C, Gonzalez PC, Milosavjlevic SV, Marshall GG, Sancha AM, Smith AH (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673–679PubMedCrossRef
39.
go back to reference Chiou HY, Hsueh YM, Liaw KF, et al (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296–1300PubMed Chiou HY, Hsueh YM, Liaw KF, et al (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296–1300PubMed
40.
go back to reference Chen Y, Ahsan H (2004) Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 94:741–744PubMed Chen Y, Ahsan H (2004) Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 94:741–744PubMed
41.
go back to reference Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RJ (1999) Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 107:359–365PubMed Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RJ (1999) Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 107:359–365PubMed
42.
go back to reference Bates MN, Rey OA, Biggs ML, et al (2004) Case–control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiology 159:381–389CrossRef Bates MN, Rey OA, Biggs ML, et al (2004) Case–control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiology 159:381–389CrossRef
43.
go back to reference Chiou HY, Chiou ST, Hsu YH, et al (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411–418PubMedCrossRef Chiou HY, Chiou ST, Hsu YH, et al (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411–418PubMedCrossRef
44.
go back to reference Kurttio P, Pukkala E, Kahelin A, Auvinen A, Pekkanen J (1999) Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705–710PubMed Kurttio P, Pukkala E, Kahelin A, Auvinen A, Pekkanen J (1999) Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705–710PubMed
45.
go back to reference Garland M, Morris JS, Colditz GA, et al (1996) Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144:653–660PubMed Garland M, Morris JS, Colditz GA, et al (1996) Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144:653–660PubMed
46.
go back to reference Pershagen G (1985) Lung cancer mortality among men living near an arsenic-emitting smelter. Am J Epidemiology 122:684–694 Pershagen G (1985) Lung cancer mortality among men living near an arsenic-emitting smelter. Am J Epidemiology 122:684–694
47.
go back to reference Hazelton WD, Leubeck EG, Heidenreich WF, Moolgavkar SH (2001) Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiation Research 156:78–94PubMedCrossRef Hazelton WD, Leubeck EG, Heidenreich WF, Moolgavkar SH (2001) Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiation Research 156:78–94PubMedCrossRef
48.
go back to reference Mabuchi K, Lilienfeld AM, Snell LM (1980) Cancer and occupational exposure to arsenic: a study of pesticide workers. Prev Med 9:51–77PubMedCrossRef Mabuchi K, Lilienfeld AM, Snell LM (1980) Cancer and occupational exposure to arsenic: a study of pesticide workers. Prev Med 9:51–77PubMedCrossRef
49.
go back to reference Coggon D, Pannett B, Acheson ED (1984) Use of job-exposure matrix in an occupational analysis of lung and bladder cancers on the basis of death certificates. JNCI 72:61–65PubMed Coggon D, Pannett B, Acheson ED (1984) Use of job-exposure matrix in an occupational analysis of lung and bladder cancers on the basis of death certificates. JNCI 72:61–65PubMed
50.
go back to reference Bates MN, Smith AH, Cantor KP (1995) Case–control study of bladder cancer and arsenic in drinking water. Am J Epidemiology 141:523–530 Bates MN, Smith AH, Cantor KP (1995) Case–control study of bladder cancer and arsenic in drinking water. Am J Epidemiology 141:523–530
51.
go back to reference Steinmaus C, Yuan Y, Bates MN, Smith AH (2003) Case–control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193–1201PubMedCrossRef Steinmaus C, Yuan Y, Bates MN, Smith AH (2003) Case–control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193–1201PubMedCrossRef
52.
go back to reference Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D (2004) Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort of male smokers. Am J Epidemiol 160:835–859CrossRef Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D (2004) Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort of male smokers. Am J Epidemiol 160:835–859CrossRef
53.
go back to reference U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program (2002) Report on Carcinogens, 10th edn. 2002 December U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program (2002) Report on Carcinogens, 10th edn. 2002 December
54.
55.
go back to reference Waalkes MP (2000) Cadmium carcinogenesis in review. J Inorg Chem 79:241–244 Waalkes MP (2000) Cadmium carcinogenesis in review. J Inorg Chem 79:241–244
56.
go back to reference Zheng H, Liu J, Choo KH, Michalska AE, Klaassen CD (1996) Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol Appl Pharmacol 136:229–235PubMedCrossRef Zheng H, Liu J, Choo KH, Michalska AE, Klaassen CD (1996) Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol Appl Pharmacol 136:229–235PubMedCrossRef
57.
go back to reference Abshire MK, Buzard GS, Shiraishi N, Waalkes MP (1996) Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health 48:359–377PubMedCrossRef Abshire MK, Buzard GS, Shiraishi N, Waalkes MP (1996) Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health 48:359–377PubMedCrossRef
58.
go back to reference Shimada H, Shiao YH, Shibata M, Waalkes MP (1998) Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health 54:159–168CrossRef Shimada H, Shiao YH, Shibata M, Waalkes MP (1998) Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health 54:159–168CrossRef
59.
go back to reference Lemen RA, Lee JS, Wagoner JK, Blejer HP (1976) Cancer mortality among cadmium production workers. Ann NY Acad Sci 271:273–279PubMedCrossRef Lemen RA, Lee JS, Wagoner JK, Blejer HP (1976) Cancer mortality among cadmium production workers. Ann NY Acad Sci 271:273–279PubMedCrossRef
60.
go back to reference Sorahan T, Watherhouse JAH (1983) Mortality study of nickel–cadmium battery workers by the method of regression models in life tables. Br J Ind Med 40:293–300PubMed Sorahan T, Watherhouse JAH (1983) Mortality study of nickel–cadmium battery workers by the method of regression models in life tables. Br J Ind Med 40:293–300PubMed
61.
go back to reference Elinder CG, Kjellstrom T, Hogstedt C, Andersson K, Spang G (1985) Cancer mortality of cadmium workers. Br J Ind Med 42:651–655PubMed Elinder CG, Kjellstrom T, Hogstedt C, Andersson K, Spang G (1985) Cancer mortality of cadmium workers. Br J Ind Med 42:651–655PubMed
62.
go back to reference Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809PubMed Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809PubMed
63.
go back to reference Kazantzis G, Lam TH, Sullivan KR (1988) Mortality of cadmium-exposed workers. Scand J Work Environ Health 14:220–223PubMed Kazantzis G, Lam TH, Sullivan KR (1988) Mortality of cadmium-exposed workers. Scand J Work Environ Health 14:220–223PubMed
64.
go back to reference Stayner L, Smith R, Thun M, Schnorr T, Lemen R (1992) A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 2:177–194PubMedCrossRef Stayner L, Smith R, Thun M, Schnorr T, Lemen R (1992) A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 2:177–194PubMedCrossRef
65.
go back to reference Sorahan T, Lister A, Gilthorpe MS, Harrington JM (1995) Mortality of copper cadmium alloy workers with special reference to lung cancer and non-malignant diseases of the respiratory system, 1946–92. Occup Environ Med 52:804–812PubMed Sorahan T, Lister A, Gilthorpe MS, Harrington JM (1995) Mortality of copper cadmium alloy workers with special reference to lung cancer and non-malignant diseases of the respiratory system, 1946–92. Occup Environ Med 52:804–812PubMed
66.
go back to reference West DW, Slattery ML, Robison LM, French TK, Mahoney AW (1991) Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85–94PubMedCrossRef West DW, Slattery ML, Robison LM, French TK, Mahoney AW (1991) Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85–94PubMedCrossRef
67.
go back to reference Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW (2002) Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288–296PubMedCrossRef Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW (2002) Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288–296PubMedCrossRef
68.
go back to reference Armstrong BG, Kazantzis G (1985) Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case–control study. Br J Ind Med 42:540–545PubMed Armstrong BG, Kazantzis G (1985) Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case–control study. Br J Ind Med 42:540–545PubMed
69.
go back to reference Miki H, Kasprzak KS, Kenney S, Heine UI (1987) Inhibition of intercellular communication by nickel (II): antagonistic effect of magnesium. Carcinogensis 8:1757–1760 Miki H, Kasprzak KS, Kenney S, Heine UI (1987) Inhibition of intercellular communication by nickel (II): antagonistic effect of magnesium. Carcinogensis 8:1757–1760
70.
go back to reference DiPaolo JA, Casto BC (1979) Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 39:1008–1013PubMed DiPaolo JA, Casto BC (1979) Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 39:1008–1013PubMed
71.
go back to reference Biedermann KA, Landolph JT (1987) Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 47:3815–3823PubMed Biedermann KA, Landolph JT (1987) Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 47:3815–3823PubMed
72.
go back to reference Patierno SR, Dirscherl L, Xu J (1993) Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutat Res 300:179–193PubMedCrossRef Patierno SR, Dirscherl L, Xu J (1993) Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutat Res 300:179–193PubMedCrossRef
73.
go back to reference Costa M (1996) Mehcanisms of nickel genotoxicity and carcinogenicity. In: Chang LW (eds) Toxicology of metals. CRC Press, Boca Raton, FL, pp 245–251 Costa M (1996) Mehcanisms of nickel genotoxicity and carcinogenicity. In: Chang LW (eds) Toxicology of metals. CRC Press, Boca Raton, FL, pp 245–251
74.
go back to reference Sen P, Conway K, Costa M (1987) Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds. Cancer Res 47:2142–2147PubMed Sen P, Conway K, Costa M (1987) Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds. Cancer Res 47:2142–2147PubMed
75.
go back to reference Kasprzak KS (1991) The role of oxidative damage in metal carcinogenicity. Chem Res Toxicol 4:604–615PubMedCrossRef Kasprzak KS (1991) The role of oxidative damage in metal carcinogenicity. Chem Res Toxicol 4:604–615PubMedCrossRef
76.
go back to reference Hartwig A, Mullenders LHF, Schlepegrell R, Kasten U, Beyersmann D (1994) Nickel (II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 54:4045–4051PubMed Hartwig A, Mullenders LHF, Schlepegrell R, Kasten U, Beyersmann D (1994) Nickel (II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 54:4045–4051PubMed
77.
go back to reference Lee YW, Klein CB, Kargacin B, et al (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15:2547–2557PubMed Lee YW, Klein CB, Kargacin B, et al (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15:2547–2557PubMed
78.
go back to reference Grimsrud TK, Berge SR, Haldorsen T, Andersen A (2002) Exposure to different forms of nickel and risk of lung cancer. Am J Epidemiol 156:1123–1132PubMedCrossRef Grimsrud TK, Berge SR, Haldorsen T, Andersen A (2002) Exposure to different forms of nickel and risk of lung cancer. Am J Epidemiol 156:1123–1132PubMedCrossRef
79.
go back to reference Grimsrud TK, Berge SR, Martinsen JI, Andersen A (2003) Lung cancer incidence among Norwegian nickel-refinery workers 1953–2000. J Environ Monit 5:190–197PubMedCrossRef Grimsrud TK, Berge SR, Martinsen JI, Andersen A (2003) Lung cancer incidence among Norwegian nickel-refinery workers 1953–2000. J Environ Monit 5:190–197PubMedCrossRef
80.
go back to reference Karjalainen S, Kerttula R, Pukkala E (1992) Cancer risk among workers at a copper/nickel smelter and nickel refinery in Finland. Int Arch Occup Environ Health 63:547–551PubMedCrossRef Karjalainen S, Kerttula R, Pukkala E (1992) Cancer risk among workers at a copper/nickel smelter and nickel refinery in Finland. Int Arch Occup Environ Health 63:547–551PubMedCrossRef
81.
go back to reference Pang, D, Burges, DCL, Sorahan, T 1996Mortality study of nickel platers with special reference to cancers of the stomach and lung, 1945–93Occup Environ Med53714717PubMed Pang, D, Burges, DCL, Sorahan, T 1996Mortality study of nickel platers with special reference to cancers of the stomach and lung, 1945–93Occup Environ Med53714717PubMed
82.
go back to reference Jarup L, Bellander T, Hogstedt C, Spang G (1998) Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 55:755–759PubMed Jarup L, Bellander T, Hogstedt C, Spang G (1998) Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 55:755–759PubMed
83.
go back to reference Andersen A, Berge SR, Engeland A, Norseth T (1996) Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup Environ Med 53:708–713PubMed Andersen A, Berge SR, Engeland A, Norseth T (1996) Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup Environ Med 53:708–713PubMed
84.
go back to reference Goldhaber SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38:232–242PubMedCrossRef Goldhaber SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38:232–242PubMedCrossRef
85.
go back to reference van’t Veer P, van der Wielen RP, Kok F, Hermus RJ, Sturmans F (1990) Selenium in diet, blood and toenails in relation to breast cancer: a case–control study. Am J Epidemiol 131:987–994 van’t Veer P, van der Wielen RP, Kok F, Hermus RJ, Sturmans F (1990) Selenium in diet, blood and toenails in relation to breast cancer: a case–control study. Am J Epidemiol 131:987–994
86.
go back to reference van’t Veer P, Strain JJ, Fernandez-Crehuet J, et al (1996) Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiol Biomark Prev 5:441–447 van’t Veer P, Strain JJ, Fernandez-Crehuet J, et al (1996) Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiol Biomark Prev 5:441–447
87.
go back to reference Ghadirian P, Maisonneuve P, Perret C, et al (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detection Prev 24: 305–313 Ghadirian P, Maisonneuve P, Perret C, et al (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detection Prev 24: 305–313
88.
go back to reference van Noord PA, de Waard F, Collette C, Mass MJ (1987) Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol 16: 318–322PubMed van Noord PA, de Waard F, Collette C, Mass MJ (1987) Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol 16: 318–322PubMed
89.
go back to reference Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC (1990) A prospective study of selenium status and breast cancer risk. JAMA 264:1128–1131PubMedCrossRef Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC (1990) A prospective study of selenium status and breast cancer risk. JAMA 264:1128–1131PubMedCrossRef
90.
go back to reference van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1994) Toenail selenium and risk of breast cancer. Am J Epidemiol 140:20–26PubMed van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1994) Toenail selenium and risk of breast cancer. Am J Epidemiol 140:20–26PubMed
91.
go back to reference Strain JJ, Bokje E, van’t Veer P, et al (1997) Thyroid hormones and selenium status in breast cancer. Nutr Cancer 27:48–52PubMed Strain JJ, Bokje E, van’t Veer P, et al (1997) Thyroid hormones and selenium status in breast cancer. Nutr Cancer 27:48–52PubMed
92.
go back to reference Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF (1988) Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 128:515–523PubMed Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF (1988) Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 128:515–523PubMed
93.
go back to reference Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, Araki E (1985) Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res 76:374–377PubMed Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, Araki E (1985) Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res 76:374–377PubMed
94.
go back to reference Willett WC, Polk BF, Morris JS, et al (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2:130–134PubMedCrossRef Willett WC, Polk BF, Morris JS, et al (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2:130–134PubMedCrossRef
95.
go back to reference Longnecker MP, Stampfer MJ, Morris JS, et al (1993) A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 57:408–413PubMed Longnecker MP, Stampfer MJ, Morris JS, et al (1993) A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 57:408–413PubMed
96.
go back to reference Morris JS, Stampfer MJ, Willett WC (1983) Dietary selenium in humans. Toenails as an indicator. Biol Trace Elem Res 5:529–537 Morris JS, Stampfer MJ, Willett WC (1983) Dietary selenium in humans. Toenails as an indicator. Biol Trace Elem Res 5:529–537
97.
go back to reference Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, Sampliner RE (1993) Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomark Prev 2:41–46 Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, Sampliner RE (1993) Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomark Prev 2:41–46
98.
go back to reference Fernandez-Banares F, Cabre E, Esteve M, et al (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97:2103–2108PubMed Fernandez-Banares F, Cabre E, Esteve M, et al (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97:2103–2108PubMed
99.
go back to reference Nomura A, Heilbrun LK, Morris JS, Stemmermann GN (1987) Serum selenium and the risk of cancer, by specific sites: case–control analysis of prospective data. JNCI 79:103–108PubMed Nomura A, Heilbrun LK, Morris JS, Stemmermann GN (1987) Serum selenium and the risk of cancer, by specific sites: case–control analysis of prospective data. JNCI 79:103–108PubMed
100.
go back to reference Wallace K, Byers T, Morris JS, et al (2003) Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case–controls study. Cancer Epidemiol Biomark Prev 12:464–467 Wallace K, Byers T, Morris JS, et al (2003) Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case–controls study. Cancer Epidemiol Biomark Prev 12:464–467
101.
go back to reference Garland M, Morris JS, Stampfer MJ, et al (1995) Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87:497–505PubMed Garland M, Morris JS, Stampfer MJ, et al (1995) Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87:497–505PubMed
102.
go back to reference Mannisto S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, Pietinen P (2000) Toenail selenium and breast cancer – a case–control study in Finland. Eur J Clin Nutr 54:98–103PubMedCrossRef Mannisto S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, Pietinen P (2000) Toenail selenium and breast cancer – a case–control study in Finland. Eur J Clin Nutr 54:98–103PubMedCrossRef
103.
go back to reference van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. JNCI 85:224–229PubMed van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. JNCI 85:224–229PubMed
104.
go back to reference Kabuto M, Imai H, Yonezawa C, et al (1994) Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomark Prev 3:465–469 Kabuto M, Imai H, Yonezawa C, et al (1994) Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomark Prev 3:465–469
105.
go back to reference Ratnasinghe D, Tangrea JA, Forman MR, et al (2000) Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control 11:129–135PubMedCrossRef Ratnasinghe D, Tangrea JA, Forman MR, et al (2000) Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control 11:129–135PubMedCrossRef
106.
go back to reference Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomark Prev 11:1285–1291 Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomark Prev 11:1285–1291
107.
go back to reference Hartman TJ, Taylor PR, Alfthan G, et al (2002) Toenail selenium concentration and lung cancer in male smokers. Cancer Causes Control 13:923–928PubMedCrossRef Hartman TJ, Taylor PR, Alfthan G, et al (2002) Toenail selenium concentration and lung cancer in male smokers. Cancer Causes Control 13:923–928PubMedCrossRef
108.
go back to reference van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective study on selenium status and the risk of lung cancer. Cancer Res 53:4860–4865PubMed van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective study on selenium status and the risk of lung cancer. Cancer Res 53:4860–4865PubMed
109.
go back to reference Nakaji S, Fukuda S, Sakamoto J, et al (2001) Relationship between mineral and trace element concentrations in drinking water and gastric cancer mortality in Japan. Nutr Cancer 40:99–102PubMedCrossRef Nakaji S, Fukuda S, Sakamoto J, et al (2001) Relationship between mineral and trace element concentrations in drinking water and gastric cancer mortality in Japan. Nutr Cancer 40:99–102PubMedCrossRef
110.
go back to reference Kneller RW, Guo WD, Hsing AW, et al (1992) Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol Biomark Prev 1:113–118 Kneller RW, Guo WD, Hsing AW, et al (1992) Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol Biomark Prev 1:113–118
111.
go back to reference Chen SY, Liu TY, Shun CT, et al (2004) Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associates between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int J Cancer 108:606–612PubMedCrossRef Chen SY, Liu TY, Shun CT, et al (2004) Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associates between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int J Cancer 108:606–612PubMedCrossRef
112.
go back to reference Zhang L, Blot WJ, You WC, et al (1994) Serum micronutrients in relation to pre-cancerous gastric lesions. Int J Cancer 56:650–654PubMed Zhang L, Blot WJ, You WC, et al (1994) Serum micronutrients in relation to pre-cancerous gastric lesions. Int J Cancer 56:650–654PubMed
113.
go back to reference Knekt P, Aromaa A, Maatela J, et al (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. JNCI 82:864–868PubMed Knekt P, Aromaa A, Maatela J, et al (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. JNCI 82:864–868PubMed
114.
go back to reference Wei WQ, Abnet CC, Qiao YL, et al (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79:80–85PubMed Wei WQ, Abnet CC, Qiao YL, et al (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79:80–85PubMed
115.
go back to reference Mark SD, Qiao YL, Dawsey SM, et al (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753–1763PubMedCrossRef Mark SD, Qiao YL, Dawsey SM, et al (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753–1763PubMedCrossRef
116.
go back to reference Dawsey SM, Wang GQ, Taylor PR, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:167–172 Dawsey SM, Wang GQ, Taylor PR, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:167–172
117.
go back to reference Wang GQ, Dawsey SM, Li JY, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:161–166 Wang GQ, Dawsey SM, Li JY, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:161–166
118.
go back to reference Helzlsouer KJ, Comstock GW, Morris JS (1989) Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49:6144–6148PubMed Helzlsouer KJ, Comstock GW, Morris JS (1989) Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49:6144–6148PubMed
119.
go back to reference Zeegers MP, Goldbohm A, Bode P, van den Brandt PA (2002) Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomark Prev 11:1292–1297 Zeegers MP, Goldbohm A, Bode P, van den Brandt PA (2002) Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomark Prev 11:1292–1297
120.
go back to reference Michaud DS, Hartman TJ, Taylor PR, et al (2002) No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomark Prev 11:1505–1506 Michaud DS, Hartman TJ, Taylor PR, et al (2002) No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomark Prev 11:1505–1506
121.
go back to reference Vogt TM, Ziegler RG, Graubard BI, et al (2003) Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer 103:664–670PubMedCrossRef Vogt TM, Ziegler RG, Graubard BI, et al (2003) Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer 103:664–670PubMedCrossRef
122.
go back to reference Allen NE, Morris JS, Ngwenyama RA, Key TJ (2004) A case–control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 90:1392–1396PubMedCrossRef Allen NE, Morris JS, Ngwenyama RA, Key TJ (2004) A case–control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 90:1392–1396PubMedCrossRef
123.
go back to reference Brooks JD, Metter EJ, Chan DW, et al (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034–2038PubMedCrossRef Brooks JD, Metter EJ, Chan DW, et al (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034–2038PubMedCrossRef
124.
go back to reference Helzlsouer KJ, Huang HY, Alberg AJ, et al (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018–2023PubMedCrossRef Helzlsouer KJ, Huang HY, Alberg AJ, et al (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018–2023PubMedCrossRef
125.
go back to reference Nomura AMY, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883–887 Nomura AMY, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883–887
126.
go back to reference Yoshizawa K, Willett WC, Morris SJ, et al (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. JNCI 90:1219–1224PubMedCrossRef Yoshizawa K, Willett WC, Morris SJ, et al (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. JNCI 90:1219–1224PubMedCrossRef
127.
go back to reference Li H, Stampfer MJ, Giovannucci EL, et al (2004) A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96:696–703PubMedCrossRef Li H, Stampfer MJ, Giovannucci EL, et al (2004) A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96:696–703PubMedCrossRef
128.
go back to reference van den Brandt PA, Zeegers MPA, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 12:866–871 van den Brandt PA, Zeegers MPA, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 12:866–871
129.
go back to reference Hartman TJ, Albanes D, Pietinen P, et al (1998) The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomark Prev 7:335–340 Hartman TJ, Albanes D, Pietinen P, et al (1998) The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomark Prev 7:335–340
130.
go back to reference Clark LC, Dalkin B, Krongrad A, et al (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734PubMed Clark LC, Dalkin B, Krongrad A, et al (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734PubMed
131.
go back to reference Prasad AS, Halsted JA, Nadimi M (1961) Syndrome of iron deficiency anemia, hepatospenomegaly, hyopgonadism, dwarfism,and geophagia. Am J Med 31:532–546PubMedCrossRef Prasad AS, Halsted JA, Nadimi M (1961) Syndrome of iron deficiency anemia, hepatospenomegaly, hyopgonadism, dwarfism,and geophagia. Am J Med 31:532–546PubMedCrossRef
132.
go back to reference Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR (1963) Zinc metabolism in patients with the syndrome of iron deficiency anemia, hypogonadism and dwarfism. J Lab Clin Med 61:537–549PubMed Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR (1963) Zinc metabolism in patients with the syndrome of iron deficiency anemia, hypogonadism and dwarfism. J Lab Clin Med 61:537–549PubMed
133.
go back to reference Prasad AS (1998) Zinc in human health: an update. J Trace Elem Exp Med 11:63–78CrossRef Prasad AS (1998) Zinc in human health: an update. J Trace Elem Exp Med 11:63–78CrossRef
135.
go back to reference Leccia MT, Richard MJ, Favier A, Beani JC (1999) Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res 69:177–190PubMed Leccia MT, Richard MJ, Favier A, Beani JC (1999) Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res 69:177–190PubMed
136.
go back to reference Gupta SK, Shukla VK, Vaidya MP, Roy SK, Gupta S (1991) Serum trace elements and Cu/Zn ratio in breast cancer patients. J Surg Oncol 46:178–181PubMed Gupta SK, Shukla VK, Vaidya MP, Roy SK, Gupta S (1991) Serum trace elements and Cu/Zn ratio in breast cancer patients. J Surg Oncol 46:178–181PubMed
137.
go back to reference Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case–control study in Germany. Nutr Cancer 46:131–137PubMedCrossRef Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case–control study in Germany. Nutr Cancer 46:131–137PubMedCrossRef
138.
go back to reference Harris RWC, Key TJA, Silcocks PB, Bull D, Wald NJ (1991) A case–control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer 15:63–68PubMed Harris RWC, Key TJA, Silcocks PB, Bull D, Wald NJ (1991) A case–control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer 15:63–68PubMed
139.
go back to reference Cocco PL, Carta P, Belli S, Picchiri GF, Flore MV (1994) Mortality of Sardinian lead and zinc miners: 1960–88. Occup Environ Med 51:674–682PubMedCrossRef Cocco PL, Carta P, Belli S, Picchiri GF, Flore MV (1994) Mortality of Sardinian lead and zinc miners: 1960–88. Occup Environ Med 51:674–682PubMedCrossRef
140.
go back to reference Zhang ZF, Kurtz RC, Yu GP, et al (1997) Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27:298–309PubMed Zhang ZF, Kurtz RC, Yu GP, et al (1997) Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27:298–309PubMed
141.
go back to reference Costello LC, Franklin RB, Tan M, Bagasra O (2005) Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 16:901–915PubMedCrossRef Costello LC, Franklin RB, Tan M, Bagasra O (2005) Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 16:901–915PubMedCrossRef
142.
go back to reference Kolonel LN, Yoshizawa CN, Hankin JH (1988) Diet and prostatic cancer: a case–control study in Hawaii. Am J Epidemiol 127:999–1012PubMed Kolonel LN, Yoshizawa CN, Hankin JH (1988) Diet and prostatic cancer: a case–control study in Hawaii. Am J Epidemiol 127:999–1012PubMed
143.
go back to reference Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95:1004–1007PubMed Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95:1004–1007PubMed
144.
go back to reference Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE (1999) Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8:887–892PubMed Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE (1999) Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8:887–892PubMed
145.
go back to reference Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI (1997) Diet and prostate cancer: a case–control study. Eur J Nutr 33:101–107 Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI (1997) Diet and prostate cancer: a case–control study. Eur J Nutr 33:101–107
Metadata
Title
Trace elements and cancer risk: a review of the epidemiologic evidence
Authors
Stephanie A. Navarro Silvera
Thomas E. Rohan
Publication date
01-02-2007
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 1/2007
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0057-z

Other articles of this Issue 1/2007

Cancer Causes & Control 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine